Class I (most serious) Medical Device Z-2682-2026 Ongoing

A leak risk in the part packed with every pump — eight in ten device records are Class II, and this is the other two (Abiomed)

Abiomed, Inc. Reported Jul 22, 2026

The U.S. FDA classified Abiomed's Impella CP pump sets as a Class I recall, its most serious category, citing a potential for leakage from the introducer sheath that is supplied with the pump. The recall covers 87,277 units distributed worldwide.

Recall overview (primary data)

  • ClassificationClass I (most serious)
  • Product typeMedical Device
  • Recalling firmAbiomed, Inc.
  • ReasonA potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.
  • DistributionWorldwide distribution. US Nationwide, Australia (AU), Austria (AT), Belgium (BE), Brazil (BR), Brunei (BN), Canada (CA), China (CN), Croatia (HR), Czech Republic (CZ), Denmark (DK), Finland (FI), Fr...
  • Recall initiated2026-06-11

Key points

  • The FDA classified it Class I, its most serious category (Z-2682-2026, reported July 22, 2026, status ongoing).
  • The recall covers the ABIOMED Impella CP Set (pump set code 0048-0003) with its 14 Fr introducer (product code 0052-3046) — 87,277 units.
  • The defect is potential leakage from under the sheath cap and along the hub score lines in 14 Fr and 23 Fr introducers.
  • FDA records state the manufacturing issue is not visually detectable by the user.
  • A 14 Fr or 23 Fr introducer is provided in every pump set, so the issue reaches across the product line.
  • The 779 device records this site holds as of 2026-09-01 split 137 Class I to 642 Class II — eight in ten are Class II.

1The Impella and its introducer

The Impella is a device placed inside the heart via catheter that pumps blood to support a weakened heart. To bring the device into the vessel, a sheath called an introducer is first inserted into the blood vessel, and the catheter is then advanced through it.

The introducer is not the device itself but the pathway to it — yet because it sits in a large vessel, leakage from it connects directly to problems such as bleeding or air entry.

2Where the leakage can occur

The defect here is a potential for leakage from under the sheath cap and along the hub score lines — the scored grooves on the connector at the operator's end. What FDA records treat as especially weighty is the explicit statement that this manufacturing issue is not visually detectable by the user. In other words, inspecting the exterior before use does not let a clinician identify an affected unit.

3Why every pump set is affected

Further, a 14 Fr or 23 Fr introducer is described as being provided in every pump set.

That means the issue is not confined to one separately sold component but reaches across the product line — which is the background to a recall quantity of 87,277 units and distribution spanning U.S. nationwide plus Australia, Austria, Belgium, Brazil, Brunei, Canada, China, Croatia, the Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, and many other countries.

4Why it matters

5Eight in ten device records are Class II

Sorting the 779 device records this site holds as of 2026-09-01 by classification gives 137 in the most serious Class I and 642 in Class II.

Class II (temporary or reversible effects)642 / 779
Class I (reasonable probability of serious harm)137 / 779

Eight in ten are Class II, and this record falls in the other two. Most device recalls concern faults that amount to inconvenience in use. Class I attaches where, as here, the fault reaches a component used on a path into the body or in sustaining life.

Why it matters

In medical devices assembled from multiple components, manufacturing variation in an accessory rather than the headline device can determine overall safety. Here a defect that cannot be screened visually spread through a component included in every pump set, reaching roughly 87,000 units across dozens of countries. Inventory systems that can reconcile stock instantly by GTIN, product code and batch — plus a plan for securing substitute equipment — are the practical safeguards on the hospital side.

FAQ

What is an introducer?
A sheath inserted into a blood vessel in advance so that catheters and other instruments can be passed through it. It is the pathway rather than the device itself, but because it sits in a large vessel, leakage is a serious concern.
Why does this reach so many products?
According to FDA records, a 14 Fr or 23 Fr introducer is provided in every pump set, so the affected scope extends across the product line rather than to a single separately sold item.
Can affected units be spotted before use?
FDA records state explicitly that the manufacturing issue is not visually detectable by the user. Identification relies on matching product codes, GTINs and batches.

Sources (primary)

Source: openFDA (U.S. FDA, CC0 public domain). Data is provided as-is and must not be used for medical decisions. Verify the latest and exact details with the official FDA recall information. This site is not endorsed or certified by the U.S. FDA.

#FDA#Recall#Class I#Medical device#Circulatory support#Impella#Catheter
Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.